Results 201 to 210 of about 79,249 (245)
Comprehensive dissection of rectal cancer organoids in responses to chemoradiation. [PDF]
Cell Rep MedXu X +26 more
europepmc +1 more source
Patient-derived organoids for the personalized treatment of pancreatic neuroendocrine tumor with liver metastases: A case report. [PDF]
World J Gastrointest OncolYang XM +7 more
europepmc +1 more source
Oxyresveratrol Alleviates Irinotecan-Induced Diarrhea and Enhances Antitumor Effects in Colorectal Cancer [Retraction]. [PDF]
Drug Des Devel Thereuropepmc +1 more source
Corrigendum to "Second-line treatment of PD-1 and CTLA-4 blockade combined with liposomal irinotecan plus leucovorin and fluorouracil for advanced cholangiocarcinoma: study protocol of a single-arm, prospective phase II trial". [PDF]
Ther Adv Med Oncoleuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Supportive & Palliative Care, 2007
The toxicity of irinotecan is predictable, manageable and nonadditive in the majority of patients; however, with its increasing use alone and in combination with other agents and modalities, the recognition and control of these adverse effects remain a clinical challenge.
openaire +2 more sources
The toxicity of irinotecan is predictable, manageable and nonadditive in the majority of patients; however, with its increasing use alone and in combination with other agents and modalities, the recognition and control of these adverse effects remain a clinical challenge.
openaire +2 more sources